All cancer mutations that cause drug resistance fall into one of four categories. New research has detailed each type, helping to uncover targets for drug development and identify potential effective ...

Researchers have mapped the genetic landscape of cancer drug resistance, uncovering that DNA changes can be grouped into four ...

Sarepta Therapeutics (SRPT – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst ...

Eterna Therapeutics and Factor Bioscience announced an exclusive license and collaboration agreement aimed at accelerating ...

U.S. consumer groups and two large labor unions urged the U.S. Federal Trade Commission on Thursday to block Novo Holdings, ...

Cambridge scientists and collaborators have mapped drug resistance across different cancers, highlighted DNA changes that may ...

In a perspective article published in Science, Professor Jonathan Rivnay explores next-generation bioelectronic medication.

Colossal Biosciences, which intends to create proxy species of the woolly mammoth, dodo, and Tasmanian tiger, claims it has ...

Researchers obtain detailed picture of the specific mechanisms by which each individual mutation studied impacts drug response.

In one of the case reports, a 75-year-old White man with hereditary coagulopathy presented with myasthenic crisis in the setting of acute pulmonary embolism. Chronic symptoms included diplopia, ptosis ...